Key details
Phase
Early testing / Safety & dosing
Sponsor
Basel khaled mohamed
Enrollment target
~30 participants
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 100 Years
Last updated November 2024